By University of Utah Huntsman Cancer Institute –
For the first time ever, a patient has received an allogeneic stem cell transplant using a deceased donor graft as part of a blood cancer clinical trial at Huntsman Cancer Institute at the University of Utah (the U).
An allogeneic transplant uses stem cells from a donor—rather than the patient themselves—to replace damaged or diseased bone marrow, offering potential new treatment possibilities for patients with blood cancers and other serious conditions.
